Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s selects AWS as cloud provider to develop pharma therapies
With AWS, Dr Reddy’s aims to reduce application development time by 30 per cent
OCTAVE study reveals vaccine response in patients with impaired immune systems
Preliminary data from the OCTAVE study in August 2021 showed that a significant proportion of clinically at-risk patients with…
Transgender inclusion in healthcare: Breaking barriers and creating equitable clinical trials
Jahanara Nayar Rahuldev, Diversity Equity Inclusion India Lead, Parexel accentuates that diversity, equity and inclusion in…
Cipla recalls six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI) due to container…
The company said that it is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number -…
Amneal Parkinson’s drug IPX203 needs to compete with novel subcutaneous levodopa delivery systems…
Amneal’s IPX203 is an oral extended-release (ER) capsule formulation of levodopa that is designed to sustain levodopa plasma…
Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
BDR Pharma launches Nilotinib to treat PH+ leukemia
PH+ Leukemia, encompassing Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML) are infrequent and complex types…
Samsung Biologics signs manufacturing deals worth $897 mn with Pfizer
The latest deals will see the biotech division of the Samsung Group produce biosimilar products ranging from oncology and…
Syngene to acquire multi-modal facility from Stelis Biopharma
Adds 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high…
Lupin gets tentative US FDA approval for Dolutegravir Tablets for Oral Suspension
This product will be manufactured at Lupin’s Nagpur facility in India